Home The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke
Article
Licensed
Unlicensed Requires Authentication

The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke

  • Martin Furtner , Thomas Ploner , Angelika Hammerer-Lercher , Raimund Pechlaner and Johannes Mair EMAIL logo
Published/Copyright: June 29, 2012

Abstract

Background: Cardiac troponin T (cTnT) has been reported to be a predictor of stroke outcome. We hypothesized that the high-sensitivity cTnT (hs-cTnT) assay is superior to its previous assay generation for stroke outcome prediction.

Methods: cTnT was measured on emergency department admission in 60 consecutive patients (35 males, age 69.4±13.9 years) with ischemic stroke. Adverse 90-day clinical outcome was defined as death or dependence (modified Rankin scale ≥3 or Barthel index <75).

Results: Stroke aetiology was microangiopathy in three, macroangiopathy in 17, cardiac embolism in 26, dissection in one and unknown in 13 patients. At 90-day follow-up 16 (27%) patients had an adverse outcome. Receiver operating characteristics (ROC) curve analysis yielded a significantly better performance of hs-cTnT vs. cTnT (area under ROC curve: 0.80 [95% CI 0.68–0.89] vs. 0.70 [95% CI 0.57–0.82], p=0.017). The optimal discriminator values according to ROC analysis were 5.1 ng/L (hs-cTnT assay) and 11 ng/L (4th generation cTnT assay) with: sensitivities 94% vs. 56%, specificities 57% vs. 84%, positive predictive values 44% vs. 56%, and negative predictive values 96% vs. 84%.

Conclusions: Improvements in cTnT assay sensitivity and precision at the low measuring range resulted in a more accurate prediction of ischemic stroke outcome, particularly for ruling out worse outcome.


Corresponding author: Johannes Mair, MD, Department of Internal Medicine 111 – Cardiology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria Phone: +43 512 50481314, Fax: +43 512 50422767

Received: 2012-05-09
Accepted: 2012-06-04
Published Online: 2012-06-29
Published in Print: 2012-11-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Congress Abstracts
  2. 44th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
  3. Masthead
  4. Masthead
  5. Editorials
  6. Tumor biomarkers: PSA and beyond
  7. Error reporting in transfusion medicine: an important tool to improve patient safety
  8. The measurement of 25-hydroxy vitamin D – an analytical challenge
  9. Reviews
  10. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers
  11. Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques
  12. γ′ Fibrinogen as a novel marker of thrombotic disease
  13. Mini Review
  14. Revaluating serum ferritin as a marker of body iron stores in the traceability era
  15. Genetics and Molecular Diagnostics
  16. Association of PBEF gene polymorphisms with acute lung injury, sepsis, and pneumonia in a northeastern Chinese population
  17. General Clinical Chemistry and Laboratory Medicine
  18. Brazilian laboratory indicators program
  19. Error reporting in transfusion medicine at a tertiary care centre: a patient safety initiative
  20. Application of mathematical models of system uncertainty to evaluate the utility of assay calibration protocols
  21. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays
  22. Analytical validation of the Roche 25-OH Vitamin D Total assay
  23. The new Roche Vitamin D Total assay: fit for its purpose?
  24. Improvement of a prenatal screening program for trisomy 18 in the first trimester of gestation
  25. Stability of osteopontin in plasma and serum
  26. Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit
  27. Cancer Diagnostics
  28. Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
  29. Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
  30. Cardiovascular Diseases
  31. The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery
  32. Association of the atherogenic index of plasma and oxidative stress status with weight gain during non-complicated pregnancy
  33. The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke
  34. Letters to the Editor
  35. Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples
  36. Measurement of 25-hydroxyvitamin vitamin D by liquid chromatography tandem-mass spectrometry with comparison to automated immunoassays
  37. Analytical evaluation of a new automated protein binding assay to determine 25-hydroxyvitamin D concentrations
  38. Mindray BS-800M1: a new clinical chemistry system with a flexible technology meeting quality performances
  39. Association of urinary albumin and serum high molecular weight-adiponectin with metabolic syndrome in patients with essential hypertension
  40. Measurement of nitrite in plasma and serum: still a challenging analytical task
  41. Association between serum γ-glutamyltransferase and pulmonary dysfunction
  42. Serum ferritin concentrations predict incidence of metabolic syndrome in rural Korean adults
  43. Homocysteine, folic acid and vitamin B12 levels in females with severe acne vulgaris
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0176/html
Scroll to top button